Updates

GARDP and CARB-X welcome renewed commitment by G7 leaders to address antimicrobial resistance

The Global Antibiotic Research and Development Partnership (GARDP) and Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB-X) jointly welcome the recent G7 Leaders’ Communiqué, which acknowledges the rapid rise in antimicrobial resistance (AMR) globally and renews the commitment by G7 governments to address the most dangerous drug-resistant infections. The G7 leaders declared they “will spare no efforts […]